BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 12012147)

  • 1. Syncope as a sign of occult cancers: a population-based cohort study.
    Lorenzen MOB; Farkas DK; Adelborg K; Sundbøll J; Sørensen HT
    Br J Cancer; 2020 Feb; 122(4):595-600. PubMed ID: 31857722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Double Jeopardy: Loss of FMRP Results in DSB and Down-regulated DNA Repair.
    Chakraborty A; Grageda A; Kuznetsov VA; Feng W
    21 Century Pathol; 2022; 2(5):. PubMed ID: 36688938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Relevance of the Constitutive Androstane Receptor.
    Stern S; Kurian R; Wang H
    Drug Metab Dispos; 2022 Jul; 50(7):1010-1018. PubMed ID: 35236665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integration of novel approaches demonstrates simultaneous metabolic inactivation and CAR-mediated hepatocarcinogenesis of a nitrification inhibitor.
    LaRocca JL; Rasoulpour RJ; Gollapudi BB; Eisenbrandt DL; Murphy LA; LeBaron MJ
    Toxicol Rep; 2017; 4():586-597. PubMed ID: 29159133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between antiepileptic drugs and hepatocellular carcinoma in patients with epilepsy: a population-based case-control study.
    Hung DZ; Lin CL; Li YW; Lin YN; Lee YR; Wang CN; Chen JJ; Lim YP
    Brain Behav; 2016 Nov; 6(11):e00554. PubMed ID: 27843704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical role of toxicologic pathology in a short-term screen for carcinogenicity.
    Cohen SM; Arnold LL
    J Toxicol Pathol; 2016 Oct; 29(4):215-227. PubMed ID: 27821906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small-molecule modulators of the constitutive androstane receptor.
    Cherian MT; Chai SC; Chen T
    Expert Opin Drug Metab Toxicol; 2015 Jul; 11(7):1099-114. PubMed ID: 25979168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activating CAR and β-catenin induces uncontrolled liver growth and tumorigenesis.
    Dong B; Lee JS; Park YY; Yang F; Xu G; Huang W; Finegold MJ; Moore DD
    Nat Commun; 2015 Feb; 6():5944. PubMed ID: 25661872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cause-specific mortality in adult epilepsy patients from Tyrol, Austria: hospital-based study.
    Granbichler CA; Oberaigner W; Kuchukhidze G; Bauer G; Ndayisaba JP; Seppi K; Trinka E
    J Neurol; 2015 Jan; 262(1):126-33. PubMed ID: 25344746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mode of action and human relevance analysis for nuclear receptor-mediated liver toxicity: A case study with phenobarbital as a model constitutive androstane receptor (CAR) activator.
    Elcombe CR; Peffer RC; Wolf DC; Bailey J; Bars R; Bell D; Cattley RC; Ferguson SS; Geter D; Goetz A; Goodman JI; Hester S; Jacobs A; Omiecinski CJ; Schoeny R; Xie W; Lake BG
    Crit Rev Toxicol; 2014 Jan; 44(1):64-82. PubMed ID: 24180433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular adenoma associated with long-term exposure to phenobarbital: a paediatric case report.
    Cerminara C; Bagnolo V; De Leonardis F; Coniglio A; Roberto D; Compagnone E; Curatolo P
    Childs Nerv Syst; 2012 Jun; 28(6):939-41. PubMed ID: 22124572
    [No Abstract]   [Full Text] [Related]  

  • 12. Multi-species analyses of direct activators of the constitutive androstane receptor.
    Omiecinski CJ; Coslo DM; Chen T; Laurenzana EM; Peffer RC
    Toxicol Sci; 2011 Oct; 123(2):550-62. PubMed ID: 21778469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xenobiotic metabolism, disposition, and regulation by receptors: from biochemical phenomenon to predictors of major toxicities.
    Omiecinski CJ; Vanden Heuvel JP; Perdew GH; Peters JM
    Toxicol Sci; 2011 Mar; 120 Suppl 1(Suppl 1):S49-75. PubMed ID: 21059794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epilepsy as a risk factor for cancer.
    Adelöw C; Ahlbom A; Feychting M; Johnsson F; Schwartzbaum J; Tomson T
    J Neurol Neurosurg Psychiatry; 2006 Jun; 77(6):784-6. PubMed ID: 16705202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer incidence among patients using antiepileptic drugs: a long-term follow-up of 28,000 patients.
    Lamminpää A; Pukkala E; Teppo L; Neuvonen PJ
    Eur J Clin Pharmacol; 2002 May; 58(2):137-41. PubMed ID: 12012147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lifelong cancer incidence in 47,697 patients treated for childhood cancer in the Nordic countries.
    Olsen JH; Möller T; Anderson H; Langmark F; Sankila R; Tryggvadóttír L; Winther JF; Rechnitzer C; Jonmundsson G; Christensen J; Garwicz S
    J Natl Cancer Inst; 2009 Jun; 101(11):806-13. PubMed ID: 19470947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer incidence in a cohort of Finnish male smokers.
    Malila N; Virtanen MJ; Virtamo J; Albanes D; Pukkala E
    Eur J Cancer Prev; 2006 Apr; 15(2):103-7. PubMed ID: 16523006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of cancer among patients with atopic dermatitis.
    Hagströmer L; Ye W; Nyrén O; Emtestam L
    Arch Dermatol; 2005 Sep; 141(9):1123-7. PubMed ID: 16172309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Toxic effects of antiepileptic drugs: review of 100 cases (author's transl)].
    Calatayud M; Peña P; Martínez P; Bermejo F; Alvarez Tejerina J
    Med Clin (Barc); 1981 May; 76(9):396-400. PubMed ID: 7017299
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.